These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21275180)

  • 41. Randomized controlled trial of an adjunctive sulforaphane nutraceutical in schizophrenia.
    Dickerson F; Origoni A; Katsafanas E; Squire A; Newman T; Fahey J; Xiao JC; Stallings C; Goga J; Khushalani S; Yolken R
    Schizophr Res; 2021 May; 231():142-144. PubMed ID: 33839372
    [No Abstract]   [Full Text] [Related]  

  • 42. Combination of phenobarbital and haloperidol in resistant schizophrenia.
    Prakash R; Reed RM; Bass AD
    J Clin Psychopharmacol; 1984 Dec; 4(6):362-3. PubMed ID: 6512009
    [No Abstract]   [Full Text] [Related]  

  • 43. Somatic profiles in chronic schizophrenia.
    Howard JS
    Psychosomatics; 1976; 17(1):26-31. PubMed ID: 5744
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of verapamil to treat negative symptoms in schizophrenia.
    Price WA; Pascarzi GA
    J Clin Psychopharmacol; 1987 Oct; 7(5):357. PubMed ID: 3680609
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients.
    Grüber L; Bunse T; Weidinger E; Reichard H; Müller N
    J Clin Psychiatry; 2014 Nov; 75(11):1266-7. PubMed ID: 25470089
    [No Abstract]   [Full Text] [Related]  

  • 46. No effect of haloperidol on cerebrospinal fluid acetylcholinesterase in patients with schizophrenia.
    Huff FJ; Reiter CT; Rosen J; Peters J; van Kammen DP
    Biol Psychiatry; 1988 Oct; 24(6):701-4. PubMed ID: 3167152
    [No Abstract]   [Full Text] [Related]  

  • 47. [Efficiency of homoeopathic method of therapy in ambulatory practice].
    Pokanevych VV; Simeonova NK; Horban' IeM; Mel'nyk OI
    Lik Sprava; 2007; (3):92-7. PubMed ID: 18271189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Not Available].
    Facharztmagazine R
    MMW Fortschr Med; 2021 Feb; 163(2):58. PubMed ID: 33527301
    [No Abstract]   [Full Text] [Related]  

  • 49. Investigation of the synergistic effects of haloperidol combined with Calculus Bovis Sativus in treating MK-801-induced schizophrenia in rats.
    Lei K; He GF; Zhang CL; Liu YN; Li J; He GZ; Li XP; Ren XH; Liu D
    Exp Anim; 2018 May; 67(2):163-173. PubMed ID: 29225304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chinese herbal medicine for schizophrenia.
    Rathbone J; Zhang L; Zhang M; Xia J; Liu X; Yang Y
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD003444. PubMed ID: 16235320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG; Wozniak P; Mack RJ; McCarthy BG
    Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
    Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
    Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
    [No Abstract]   [Full Text] [Related]  

  • 53. [A randomized double-blinded controlled study on treatment of schizophrenia by in vitro fostered bezoar combined with haloperidol].
    Weng SH; Wang GH; Wang XP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1213-5. PubMed ID: 21275180
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
    Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
    Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
    [No Abstract]   [Full Text] [Related]  

  • 55. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study.
    Zhang ZJ; Kang WH; Li Q; Wang XY; Yao SM; Ma AQ
    Schizophr Res; 2006 Dec; 88(1-3):102-10. PubMed ID: 16959472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.